Press Releases

Date Title and Summary
Toggle Summary CyberKnife(R) Installed Base Reaches 100 Systems Worldwide as Field of Radiosurgery Continues to Expand
Total CyberKnife Patients Treated Rises to More Than 30,000 SUNNYVALE, Calif., May 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the CyberKnife(R) Robotic Radiosurgery System install base has reached 100 systems.
Toggle Summary Accuray Reports Fiscal Third Quarter 2007 Financial Results
Click here for PDF version of this release Fiscal Third Quarter 2007 Highlights: -- Record revenue of $37.3 million, up 129 percent from the fiscal third quarter 2006 and up 42 percent from the fiscal second quarter 2007 -- Total backlog increased to $559 million, up 60 percent from the fiscal
Toggle Summary CyberKnife Technology May Provide Non-invasive Means for Cardiac Ablation
Accuray Enters Licensing Agreement with CyberHeart Incorporated SUNNYVALE, Calif., April 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it has entered into an agreement with CyberHeart Incorporated under which
Toggle Summary Accuray Incorporated to Report Third Quarter Fiscal Year 2007 Financial Results on May 1, 2007
SUNNYVALE, Calif., April 17 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced it will report results for its third quarter fiscal year 2007 on Tuesday, May 1, 2007, after the market closes.
Toggle Summary Accuray Signs Distribution and Co-Marketing Agreement with Siemens
Agreement Enables Integration of Diagnostic CT Imaging and Robotic Radiosurgery Technology in the Treatment Room SUNNYVALE, Calif., April 11, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced
Toggle Summary Accuray Surpasses 2,000 Lung Cancer Patients Treated With the CyberKnife(R) Robotic Radiosurgery System
Only Non-Invasive Radiosurgery Treatment Option that Continually Tracks Lung Tumors During Respiration SUNNYVALE, Calif., April 3, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that its
Toggle Summary Survey Confirms the CyberKnife(R) System as the Only Extracranial Radiosurgery Device in Widespread Use
SUNNYVALE, Calif., March 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY - News), a global leader in the field of radiosurgery, announced today the results of an independent survey that confirms that the CyberKnife® Robotic Radiosurgery System dominates the field of extracranial
Toggle Summary Accuray Incorporated Reports Second Quarter Fiscal 2007 Financial Results
Click here for PDF version of this release SUNNYVALE, Calif., March 15, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of robotic radiosurgery, today announced financial results for the second quarter ended December 30, 2006.
Toggle Summary CyberKnife Spinal Tumor Treatments Increase by 56 Percent
Success of Non-Invasive Procedure Chronicled in the Journal Spine SUNNYVALE, Calif., Feb. 20 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced clinical data that shows use of its CyberKnife(R) Robotic Radiosurgery System in the
Toggle Summary Accuray Incorporated Announces Underwriters' Exercise of Over-Allotment Option and Completion of Initial Public Offering
SUNNYVALE, Calif., Feb 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY) today announced the closing of its initial public offering of common stock and the exercise by the underwriters of their over-allotment option to purchase an additional 2,399,998

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.